Prof. Efrem Curcio received his PhD in Chemical Engineering and Materials in 2005 at the University of Calabria, Italy. (Co)author of >150 papers in peer-reviewed international journals. Recipient of the European Membrane Society Award 2004 for the best published paper in Membrane Science and Engineering. Participation or coordination of several international research projects (inter alia: MISTI/MIT; VII EU Framework Programme MEDINA, DEMCAMER, BIOART, REAPOWER; Horizon 2020 AMECRYS, REMIND, SEA4VALUE; Eranet-Med EXTRASEA; Horizon EU EXBRINER, MEASURED, MEMCAT, etc.). He has approximately 25 years of experience in the development of advanced membrane processes, with pioneering contributions in the field of Integrated Membrane Systems for seawater desalination and water treatment, (photothermal) membrane distillation crystallization for mineral recovery from brines, membrane bio-separation systems for the purification of proteins and mAbs, membrane systems for bioartificial organs and regenerative medicine. He is the CEO of the spin-off company Seligenda Membrane Technologies Srl.
Prof. Efrem Curcio received his PhD in Chemical Engineering and Materials in 2005 at the University of Calabria, Italy. (Co)author of >150 papers in peer-reviewed international journals. Recipient of the European Membrane Society Award 2004 for the best published paper in Membrane Science and Engineering. Participation or coordination of several international research projects (inter alia: MISTI/MIT; VII EU Framework Programme MEDINA, DEMCAMER, BIOART, REAPOWER; Horizon 2020 AMECRYS, REMIND, SEA4VALUE; Eranet-Med EXTRASEA; Horizon EU EXBRINER, MEASURED, MEMCAT, etc.). He has approximately 25 years of experience in the development of advanced membrane processes, with pioneering contributions in the field of Integrated Membrane Systems for seawater desalination and water treatment, (photothermal) membrane distillation crystallization for mineral recovery from brines, membrane bio-separation systems for the purification of proteins and mAbs, membrane systems for bioartificial organs and regenerative medicine. He is the CEO of the spin-off company Seligenda Membrane Technologies Srl.